Palmitic Acid

Palmitic Acid

SCHEMBL4391708

CCCCCCCCCCCCCCCC(=O)O.N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 1/20 0.67
GRM6 O15303 1/20 0.67
GRIN2D O15399 1/20 0.67
GRIN3B O60391 1/20 0.67
GSR P00390 1/20 0.67
CYP1A2 P05177 1/20 0.67
GRIK1 P39086 1/20 0.67
GRM5 P41594 1/20 0.67
GRIA1 P42261 1/20 0.67
GRIA2 P42262 1/20 0.67
GRIA3 P42263 1/20 0.67
SLC1A3 P43003 1/20 0.67
SLC1A2 P43004 1/20 0.67
SLC1A1 P43005 1/20 0.67
GRIA4 P48058 1/20 0.67
GRIN1 Q05586 1/20 0.67
GRIN2A Q12879 1/20 0.67
GRIK2 Q13002 1/20 0.67
GRIK3 Q13003 1/20 0.67
GRIN2B Q13224 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Myristic Acid SCHEMBL28211043 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Dodecanoate SCHEMBL28392111 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Octanoic Acid SCHEMBL28246078 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Decanoic Acid SCHEMBL1045578 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Palmitic Acid SCHEMBL4391707 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Stearic Acid SCHEMBL4391220 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Dodecanoate SCHEMBL28371028 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Decanoic Acid SCHEMBL6751319 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Stearic Acid SCHEMBL4391222 1.00 GRM8 (0.67) GRM8GRM6GRIN2DGRIN3BGSR
Decanoic Acid SCHEMBL13278749 0.98 GRM8 (0.64) GRM8GRM6GRIN2DGRIN3BGSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10175233-B2 Biomarkers for cardiovascular diseases and methods using the same METABOLON, INC. (US) 2019-01-08 US disclosed
US-20160178620-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2016-06-23 US disclosed
US-9250225-B2 Biomarkers for insulin resistance and methods using the same METABOLON, INC. (US) 2016-02-02 US disclosed
US-20150005195-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2015-01-01 US disclosed
US-8809008-B2 Biomarkers for impaired glucose tolerance and methods using the same METABOLON, INC. (US) 2014-08-19 US disclosed
US-20130338031-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2013-12-19 US disclosed
EP-2164977-B1 BIOMARKERS FOR PRE-DIABETES AND METHODS USING THE SAME METABOLON INC (US) 2013-10-30 EP disclosed
US-8546098-B2 Biomarkers for monitoring insulin resistance and methods using the same METABOLON, INC. (US) 2013-10-01 US disclosed
US-20120208215-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. (US) 2012-08-16 US disclosed
US-8187830-B2 Method for determining insulin sensitivity with biomarkers METABOLON, INC. (US) 2012-05-29 US disclosed
US-20090155826-A1 Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same METABOLON, INC. (US) 2009-06-18 US disclosed